Latest Articles & Resources FEATURED Oligonucleotide CDMO: Manufacturing Services, Market Report & Outsourcing Guide Read More » Oligonucleotide CDMO: Manufacturing Services, Market Report & Outsourcing Guide Read More » LATEST NEWS + INTERVIEWS NorthStar Partners With LIFT to Advance Lu177-LT17 Radioligand Therapy Porton Advanced Supports Dual U.S. and China IND Clearances for YB1-X7 Biomerica Signs $1.75 Million IVD Development Agreement Under New CDMO Contract Biointron Expands CRO Antibody Services With Rapid RushMab Expression Packages Parexel Highlights Real-World Oncology Research and Expands CRO Evidence Capabilities CDMO Industry Leaders on Resilience, Capability Gaps, and the Partnerships That Will Define the Next Decade Quotient Sciences Initiates Phase I Study for AI-Designed Drug Product CellCarta and Sonic Healthcare Partner to Expand CRO Biomarker Testing Network Momentum Biotechnologies Launches CHIPP Assay for Proteome-Wide, High-Throughput Drug Target Deconvolution Intravacc Secures French CIR Approval for 2025–2027 VectorBuilder Invests $50 Million in Chicago Biomanufacturing Center QSA Global Signs Multi-Year Ra-226 Supply Agreement With NorthStar WuXi Biologics Completes GMP Release for Shanghai Drug Product Facility Minaris Expands Rapid Mycoplasma Testing With 3-Day Turnaround Capability ProBioGen Launches AGE1.CR.ReX Platform for Recombinant MVA Production Almac Group Reports £1.1 Billion Revenue in Record Financial Year InSphero Acquires CRO PhenoVista Biosciences to Strengthen U.S. Presence and High-Content Imaging Capabilities 3PBIOVIAN Expands Mammalian Platform With New 2,000 L Bioreactor CordenPharma to Acquire AmbioPharm, Expanding Global Peptide API Manufacturing Network NorthX Biologics and enGenes Launch Integrated E. coli Manufacturing Pathway WuXi Vaccines Receives ANVISA GMP Certification for Dengue Vaccine Facility PODCAST INTERVIEWS Beyond the VC Round: Creative Financing Strategies for Biotech’s Bear Market Decarbonizing Pharma: Why Green Chemistry Must Lead the Sustainability Agenda How Kindeva’s $200M Sterile Injectable Investment Is Setting a New Compliance Benchmark for CDMOs
CDMO Industry Leaders on Resilience, Capability Gaps, and the Partnerships That Will Define the Next Decade
Momentum Biotechnologies Launches CHIPP Assay for Proteome-Wide, High-Throughput Drug Target Deconvolution
InSphero Acquires CRO PhenoVista Biosciences to Strengthen U.S. Presence and High-Content Imaging Capabilities
